Sara Ricardo

2.2k total citations · 1 hit paper
54 papers, 1.7k citations indexed

About

Sara Ricardo is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sara Ricardo has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 28 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sara Ricardo's work include Cancer Cells and Metastasis (9 papers), Ovarian cancer diagnosis and treatment (9 papers) and Glycosylation and Glycoproteins Research (6 papers). Sara Ricardo is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Ovarian cancer diagnosis and treatment (9 papers) and Glycosylation and Glycoproteins Research (6 papers). Sara Ricardo collaborates with scholars based in Portugal, Spain and Brazil. Sara Ricardo's co-authors include Fernando Schmitt, José Cameselle‐Teijeiro, Fernanda Milanezi, Joana Paredes, Dina Leitão, Renê Gerhard, André Filipe Vieira, Regina Pinto, Fátima Baltazar and Céline Pinheiro and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Sara Ricardo

51 papers receiving 1.7k citations

Hit Papers

Breast cancer stem cell markers CD44, CD24 and ALDH1: exp... 2011 2026 2016 2021 2011 100 200 300 400

Peers

Sara Ricardo
Sara Ricardo
Citations per year, relative to Sara Ricardo Sara Ricardo (= 1×) peers Simonetta Buglioni

Countries citing papers authored by Sara Ricardo

Since Specialization
Citations

This map shows the geographic impact of Sara Ricardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Ricardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Ricardo more than expected).

Fields of papers citing papers by Sara Ricardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Ricardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Ricardo. The network helps show where Sara Ricardo may publish in the future.

Co-authorship network of co-authors of Sara Ricardo

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Ricardo. A scholar is included among the top collaborators of Sara Ricardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Ricardo. Sara Ricardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silva, Rita, Elena Fiorini, Silva Mulhovo, et al.. (2025). A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 44(1). 129–129. 3 indexed citations
2.
Osório, Hugo, Cláudia Lobo, Paula Monteiro, et al.. (2024). Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression. Biochemistry and Biophysics Reports. 39. 101755–101755. 3 indexed citations
3.
Silva, Patrícia M. A., et al.. (2024). Metformin Impairs Linsitinib Anti-Tumor Effect on Ovarian Cancer Cell Lines. International Journal of Molecular Sciences. 25(22). 11935–11935.
4.
Rodrigues, Adriana R., Liliana Matos, J.J.N. Costa, et al.. (2024). Antioxidant treatment attenuates age-related placenta GLUT-1 and PLIN-2 downregulation. Placenta. 160. 60–66. 1 indexed citations
5.
Ricardo, Sara, et al.. (2024). Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures. Pharmaceuticals. 18(1). 14–14.
6.
Silvestre, Ricardo, et al.. (2023). Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins. International Journal of Molecular Sciences. 25(1). 323–323. 6 indexed citations
7.
Harrison, Philip J., Johan Heldin, Sara Ricardo, et al.. (2022). A method for Boolean analysis of protein interactions at a molecular level. Nature Communications. 13(1). 4755–4755. 10 indexed citations
8.
Monteiro, Luı́s, Leonor Delgado, Barbas do Amaral, et al.. (2022). Occludin and claudin-1 are potential prognostic biomarkers in patients with oral squamous cell carcinomas: An observational study. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 134(5). 588–598. 4 indexed citations
9.
Ricardo, Sara, Diana Martins, Ana C. Magalhães, et al.. (2022). Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression. Cancers. 14(11). 2582–2582. 2 indexed citations
10.
Silva, Patrícia M. A., et al.. (2021). Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein. Frontiers in Oncology. 11. 752127–752127. 16 indexed citations
11.
Coelho, Ricardo, Lara Marcos-Silva, Nuno Mendes, et al.. (2018). Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours. International Journal of Molecular Sciences. 19(7). 2045–2045. 24 indexed citations
12.
Marcos-Silva, Lara, Sara Ricardo, Kowa Chen, et al.. (2015). A novel monoclonal antibody to a defined peptide epitope in MUC16. Glycobiology. 25(11). 1172–1182. 17 indexed citations
13.
Monteiro, Luı́s, Leonor Delgado, Sara Ricardo, et al.. (2013). Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 115(5). 638–645. 32 indexed citations
14.
Gerhard, Renê, Sara Ricardo, André Albergaria, et al.. (2012). Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas. The Breast. 21(3). 354–360. 39 indexed citations
15.
Ricardo, Sara, André Filipe Vieira, Renê Gerhard, et al.. (2011). Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. Journal of Clinical Pathology. 64(11). 937–946. 491 indexed citations breakdown →
16.
Reis‐Filho, Jorge S., Sara Ricardo, Fátima Gärtner, & Fernando Schmitt. (2004). Bilateral Gonadoblastomas in a Dog with Mixed Gonadal Dysgenesis. Journal of Comparative Pathology. 130(2-3). 229–233. 12 indexed citations
17.
Carvalho, Sílvia, Fernanda Milanezi, Sara Ricardo, et al.. (2004). c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations?. Journal of Clinical Pathology. 57(10). 1075–1079. 38 indexed citations
18.
Reis‐Filho, Jorge S., Ana Preto, Paula Soares, et al.. (2003). p63 Expression in Solid Cell Nests of the Thyroid: Further Evidence for a Stem Cell Origin. Modern Pathology. 16(1). 43–48. 79 indexed citations
20.
Preto, Ana, Jorge S. Reis‐Filho, Sara Ricardo, & Paula Soares. (2002). P63 Expression in Papillary and Anaplastic Carcinomas of the Thyroid Gland: Lack of an Oncogenetic Role in Tumorigenesis and Progression. Pathology - Research and Practice. 198(7). 449–454. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026